CHARACTERIZATION OF FOCAL LIVER LESIONS WITH CONTRAST-ENHANCED ULTRASOUND

被引:110
作者
Piscaglia, Fabio [1 ]
Lencioni, Riccardo [2 ]
Sagrini, Elisabetta [1 ]
Pina, Clotilde Dalla [2 ]
Cioni, Dania [2 ]
Vidili, Giampaolo [1 ]
Bolondi, Luigi [1 ]
机构
[1] Univ Bologna, Div Internal Med, Dept Clin Med, Bologna, Italy
[2] Univ Pisa, Div Diagnost & Intervent Radiol, Pisa, Italy
关键词
Ultrasonography; Microbubbles; Liver neoplasms; HEPATOCELLULAR-CARCINOMA; NODULAR HYPERPLASIA; DIAGNOSTIC-CRITERIA; CIRRHOTIC-PATIENTS; SONOGRAPHY; ADENOMA; DIFFERENTIATION; AGENT; TUMORS; CLASSIFICATION;
D O I
10.1016/j.ultrasmedbio.2010.01.004
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
The introduction of second generation microbubble ultrasound (US) contrast agents, such as SonoVue (Bracco, Milan, Italy), has considerably improved the diagnostic yield of US imaging for the evaluation of focal hepatic lesions in recent years because of its ability to very sensitively depict tumoral vascularity. In addition, contrast-enhanced US (CEUS) has the advantage of the absence of ionizing radiation, the widespread availability, even at the bedside, and the possibility to characterize a lesion as soon as detected on conventional B-mode US, commonly used as the first technique for exploration of the liver. The present review focuses on the basic principles of the technique and the various patterns of benign and malignant hepatic lesions at CEUS, contributing to their characterization. Understanding of these enhancement features at CEUS according to the type of tumors enables to make more accurate characterization of focal liver lesions as well as give better advice to oncologists, hepatologists or other clinicians in case of suspected liver tumors. (E-mail: fabio.piscaglia@unibo.it) (C) 2010 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:531 / 550
页数:20
相关论文
共 59 条
[1]   Detection and characterisation of liver metastases [J].
Albrecht, T ;
Hohmann, J ;
Oldenburg, A ;
Skrok, J ;
Wolf, KJ .
EUROPEAN RADIOLOGY, 2004, 14 :P25-P33
[2]   Familial liver adenomatosis associated with hepatocyte nuclear factor 1α inactivation [J].
Bacq, Y ;
Jacquemin, E ;
Balabaud, C ;
Jeannot, E ;
Scotto, B ;
Branchereau, S ;
Laurent, C ;
Bourlier, P ;
Pariente, D ;
De Muret, A ;
Fabre, M ;
Bioulac-Sage, P ;
Zucman-Rossi, J .
GASTROENTEROLOGY, 2003, 125 (05) :1470-1475
[3]   Differentiation of hepatocellular adenoma and focal nodular hyperplasia of the liver: comparison of power Doppler imaging and conventional color Doppler sonography [J].
Bartolozzi, C ;
Lencioni, R ;
Paolicchi, A ;
Moretti, M ;
Armillotta, N ;
Pinto, F .
EUROPEAN RADIOLOGY, 1997, 7 (09) :1410-1415
[4]   Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results [J].
Bertolotto, M ;
Dalla Palma, L ;
Quaia, E ;
Locatelli, M .
EUROPEAN RADIOLOGY, 2000, 10 (09) :1369-1376
[5]   Hepatocellular adenoma subtype classification using molecular markers and lmmunohistochemistry [J].
Bioulac-Sage, Paulette ;
Rebouissou, Sandra ;
Thomas, Cristel ;
Blanc, Jean-Frederic ;
Saric, Jean ;
Cunha, Antonio Sa ;
Ruiller, Anne ;
Cubel, Gaeelle ;
Couchy, Gabrielle ;
Imbeaud, Sandrine ;
Balabaud, Charles ;
Zucman-Rossi, Jessica .
HEPATOLOGY, 2007, 46 (03) :740-748
[6]   Science, medicine, and the future - Microbubble contrast agents: a new era in ultrasound [J].
Blomley, MJK ;
Cooke, JC ;
Unger, EC ;
Monaghan, MJ ;
Cosgrove, DO .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7296) :1222-1225
[7]   Characterization of small nodules in cirrhosis by assessment of vascularity: The problem of hypovascular hepatocellular carcinoma [J].
Bolondi, L ;
Gaiani, S ;
Celli, N ;
Goffieri, R ;
Grigioni, WF ;
Leoni, S ;
Venturi, AM ;
Piscaglia, F .
HEPATOLOGY, 2005, 42 (01) :27-34
[8]   Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis [J].
Bolondi, L ;
Sofia, S ;
Siringo, S ;
Gaiani, S ;
Casali, A ;
Zironi, G ;
Piscaglia, F ;
Gramantieri, L ;
Zanetti, M ;
Sherman, M .
GUT, 2001, 48 (02) :251-259
[9]   New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice [J].
Bolondi, L. ;
Correas, J. M. ;
Lencioni, R. ;
Weskott, H. P. ;
Piscaglia, F. .
DIGESTIVE AND LIVER DISEASE, 2007, 39 (02) :187-195
[10]   Screening for hepatocellular carcinoma in cirrhosis [J].
Bolondi, L .
JOURNAL OF HEPATOLOGY, 2003, 39 (06) :1076-1084